Literature DB >> 10600607

Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection.

P K Nicholls1, B A Klaunberg, R A Moore, E B Santos, N R Parry, G W Gough, M A Stanley.   

Abstract

Papillomaviruses occasionally cause severe, nonregressing or recurrent infections in their human and animal hosts. The mechanisms underlying these atypical infections are not known. Canine oral papillomavirus (COPV) typically regresses spontaneously and is an important model of mucosal human papillomavirus infections. A severe, naturally occurring, nonregressing COPV infection provided an opportunity to investigate some aspects of viral pathogenicity and host immunity. In this case, the papillomas proved refractory to surgical and medical treatments, including autogenous vaccination and vaccination with capsid (L1) virus-like particles. High levels of induced anti-L1 antibodies appeared to have no effect on the infection. The papillomas spread to oesophageal mucosa, perioral haired skin, and remote cutaneous sites. Isolation of COPV from the animal and sequencing of several regions of the viral genome showed no differences to the COPV prototype. Experimental infection of beagle dogs with this viral isolate resulted in the uncomplicated development and regression of oral warts within the usual period, indicating that the virus was not an unusual pathogenic variant. These findings support the hypothesis that the recurrent lesions seen in some human papillomavirus infections, such as recurrent laryngeal papillomatosis, are associated with specific defects in host immunity rather than variations in viral pathogenicity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600607     DOI: 10.1006/viro.1999.0060

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences.

Authors:  N D Christensen; R Han; N M Cladel; M D Pickel
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes.

Authors:  Philipp Lohneis; Sengül Boral; Andreas M Kaufmann; Annika Lehmann; Christiane Schewe; Manfred Dietel; Ioannis Anagnostopoulos; Korinna Jöhrens
Journal:  Virchows Arch       Date:  2014-12-28       Impact factor: 4.064

Review 3.  Epithelial cell responses to infection with human papillomavirus.

Authors:  Margaret A Stanley
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Characterization of canine oral papillomavirus by histopathological and genetic analysis in Korea.

Authors:  Ji-Young Yhee; Byung-Joon Kwon; Jong-Hyuk Kim; Chi-Ho Yu; Keum-Soon Im; Sung-Seok Lee; Young-Soo Lyoo; Byung-Joon Chang; Jung-Hyang Sur
Journal:  J Vet Sci       Date:  2010-03       Impact factor: 1.672

5.  Multicenter initiative seeking critical genes in respiratory papillomatosis.

Authors:  Farrel J Buchinsky; Craig S Derkay; Suzanne M Leal; Joseph Donfack; Garth D Ehrlich; J Christopher Post
Journal:  Laryngoscope       Date:  2004-02       Impact factor: 3.325

Review 6.  Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia.

Authors:  Nagayasu Egawa; Kiyofumi Egawa; Heather Griffin; John Doorbar
Journal:  Viruses       Date:  2015-07-16       Impact factor: 5.048

7.  Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis.

Authors:  P Albert Arockia Raj; Selvaraj Pavulraj; M Asok Kumar; S Sangeetha; R Shanmugapriya; S Sabithabanu
Journal:  Vet World       Date:  2020-01-31

8.  Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Authors:  Woei Ling Peh; Kate Middleton; Neil Christensen; Philip Nicholls; Kiyofumi Egawa; Karl Sotlar; Janet Brandsma; Alan Percival; Jon Lewis; Wen Jun Liu; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Immunologic Control of Mus musculus Papillomavirus Type 1.

Authors:  Joshua W Wang; Rosie Jiang; Shiwen Peng; Yung-Nien Chang; Chien-Fu Hung; Richard B S Roden
Journal:  PLoS Pathog       Date:  2015-10-23       Impact factor: 6.823

10.  The biology of papillomavirus latency.

Authors:  Gareth Adam Maglennon; John Doorbar
Journal:  Open Virol J       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.